PROTEUS results reshape high‑risk localized prostate cancer care, adding apalutamide plus androgen deprivation before surgery as a new option.
Mary-Ellen Taplin, MD, FASCO
Advertisement
Articles by Mary-Ellen Taplin, MD, FASCO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale
2
ACA Enrollment Erosion Deepens After Open Enrollment Ends
3
Efgartigimod Effective in Broad Subsets of Patients With gMG
4
What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO
5